Written by Klarity Editorial Team
Published: Jul 20, 2026

Last updated: July 20, 2026
If you have Aetna insurance in Maine and you or a family member is dealing with depression, understanding your coverage can make the difference between getting help quickly and facing unexpected costs. Aetna is one of Maine’s major health insurers, and this guide explains how Aetna’s depression benefits work in Maine, which antidepressants CVS/Caremark typically covers, how Maine’s mental health parity law protects you, and how Klarity Health can help you connect with a licensed provider.
Ready to see if Aetna may cover your depression treatment? Check your options at Klarity Health →
Key Facts. Aetna Depression Coverage in Maine
- Insurer: Aetna Health of Maine / Aetna Life Insurance Company
- PBM (Pharmacy Benefit Manager): CVS/Caremark
- Mental health parity law: Me. Rev. Stat. Ann. tit. 24-A, § 2749-A (fully-insured commercial plans)
- ERISA self-funded plans: Federal Mental Health Parity and Addiction Equity Act (MHPAEA) applies
- Maine EPCS: Standard antidepressants are non-scheduled. EPCS entirely inapplicable. Spravato (esketamine, Schedule III) = EPCS REQUIRED in Maine.
- Aetna member services: 1-800-872-3862
- CVS/Caremark pharmacy: 1-800-552-8159
- Maine Bureau of Insurance: 1-800-300-5000
Aetna plans sold in Maine generally cover depression treatment as an essential health benefit. Under Maine’s mental health parity law (Me. Rev. Stat. Ann. tit. 24-A, § 2749-A), fully-insured commercial plans must cover mental health conditions, including major depressive disorder, at parity with general medical and surgical benefits. This means Aetna may not impose more restrictive prior authorization rules, step therapy requirements, or higher cost-sharing for depression care than it does for comparable physical health conditions.
Covered services typically include:
Coverage details vary by plan tier, employer group, and benefit design. Always verify your specific benefits by calling Aetna member services at 1-800-872-3862 before scheduling an appointment.
Maine’s mental health parity statute, Me. Rev. Stat. Ann. tit. 24-A, § 2749-A, requires fully-insured health insurance plans issued in Maine to provide coverage for mental health and substance use disorders at parity with medical and surgical benefits. For depression specifically, this means:
If you believe Aetna is applying more restrictive limits to your depression treatment than to comparable medical care, you may file a parity complaint with the Maine Bureau of Insurance at 1-800-300-5000.
Aetna’s behavioral health benefits for depression in Maine typically include the following levels of care, subject to medical necessity criteria:
Outpatient visits with a psychiatrist, licensed clinical social worker (LCSW), or therapist are generally covered. Under parity, Aetna may not apply visit limits that are stricter than those for general medical specialist visits. Telehealth is covered at parity with in-person care under Maine law.
IOP (typically 9+ hours/week of structured therapy) and PHP (typically 20+ hours/week, often as a step-down from inpatient) are covered when Aetna’s clinical criteria for medical necessity are met. These programs are appropriate for moderate-to-severe depression that has not responded to standard outpatient care.
Acute inpatient stays for severe or treatment-resistant depression are covered when medically necessary. Aetna conducts utilization review; parity rules prohibit more stringent concurrent review than applies to comparable medical admissions.
Prescription antidepressants are covered through CVS/Caremark. See the formulary table below for tier placements and prior authorization requirements.
Aetna uses CVS/Caremark as its pharmacy benefit manager. The table below reflects typical formulary placement for common antidepressants under Aetna/CVS/Caremark plans in Maine. Specific tier placement may vary by plan; verify coverage at CVS/Caremark 1-800-552-8159 or through your Aetna member portal.
| Medication | Generic/Brand | Typical Tier | Prior Authorization | Schedule | Maine EPCS |
|---|---|---|---|---|---|
| Sertraline (Zoloft) | Generic | Tier 1 | No PA | Non-scheduled | Inapplicable |
| Escitalopram (Lexapro) | Generic | Tier 1 | No PA | Non-scheduled | Inapplicable |
| Fluoxetine (Prozac) | Generic | Tier 1 | No PA | Non-scheduled | Inapplicable |
| Bupropion XL (Wellbutrin XL) | Generic | Tier 1 | No PA | Non-scheduled | Inapplicable |
| Duloxetine (Cymbalta) | Generic | Tier 1. 2 | No PA | Non-scheduled | Inapplicable |
| Venlafaxine ER (Effexor XR) | Generic | Tier 1. 2 | No PA | Non-scheduled | Inapplicable |
| Mirtazapine (Remeron) | Generic | Tier 1 | No PA | Non-scheduled | Inapplicable |
| Trintellix (vortioxetine) | Brand | Tier 3. 4 | Step therapy required (prior SSRI trial) | Non-scheduled | Inapplicable |
| Auvelity (dextromethorphan/bupropion) | Brand | Tier 4 | PA required | Non-scheduled | Inapplicable |
| Spravato (esketamine nasal spray) | Brand | Tier 4 Specialty | PA + REMS (2+ failed antidepressant trials, TRD) | Schedule III | REQUIRED |
Note: Tier placement and PA requirements may vary by plan year and specific Aetna plan design. Verify at 1-800-872-3862 or 1-800-552-8159.
Maine operates one of the broadest Electronic Prescribing for Controlled Substances (EPCS) mandates in the country, covering Schedule II through Schedule V controlled substances. Understanding how this applies to depression medications is important for patients seeking care:
The vast majority of antidepressants prescribed for depression. Including all SSRIs (sertraline, escitalopram, fluoxetine, paroxetine), SNRIs (venlafaxine ER, duloxetine), bupropion, mirtazapine, and newer agents like Auvelity. Are non-scheduled drugs. Maine’s EPCS mandate applies only to controlled substances (Schedule II. V). These medications are entirely outside EPCS requirements and may be prescribed by paper, electronic, or any lawful method.
Spravato (esketamine nasal spray) is a Schedule III controlled substance used for treatment-resistant depression (TRD) and major depressive disorder with acute suicidal ideation or behavior (MDSI). As a Schedule III substance, it is subject to Maine’s EPCS mandate. Providers prescribing Spravato in Maine must issue the prescription electronically. Additionally, Spravato is dispensed only in certified healthcare settings under a REMS program. Patients cannot self-administer at home. CVS/Caremark requires prior authorization for Spravato, typically demanding documentation of at least two prior antidepressant failures.
For the overwhelming majority of patients with depression, EPCS has no practical impact since first-line antidepressants are non-scheduled. EPCS only becomes relevant in the narrow context of Spravato for TRD.
Under CVS/Caremark’s standard formulary management, first-line antidepressants (generic SSRIs, SNRIs, bupropion, mirtazapine) are typically available at Tier 1. 2 with no prior authorization. However, certain branded or newer agents have utilization management requirements:
Trintellix is a serotonin modulator approved for major depressive disorder. CVS/Caremark typically requires step therapy: patients must have tried and failed (or have a documented contraindication to) at least one first-line SSRI or SNRI before CVS/Caremark will approve coverage. Under Maine’s § 2749-A parity rules, Aetna must apply this step therapy requirement in a manner no more restrictive than comparable utilization management for physical health conditions.
Auvelity is a novel NMDA receptor antagonist combination approved for major depressive disorder, offering a faster onset than traditional SSRIs. CVS/Caremark typically requires prior authorization. Criteria generally include a confirmed MDD diagnosis and documentation of prior antidepressant treatment, though specific criteria vary by plan year.
Spravato is reserved for treatment-resistant depression or MDD with acute suicidal ideation. CVS/Caremark’s PA criteria for Spravato typically require:
Maine law requires insurers to have a process for step therapy exceptions. If your prescriber believes step therapy is clinically inappropriate for your situation, they may submit a step therapy exception request. Grounds for exception include: contraindication to the required first-step drug, prior failure of the required drug, clinical urgency, or documented medical necessity. Aetna must respond within 72 hours for urgent requests (24 hours for urgent life-threatening) or 30 days for standard requests.
Before scheduling an appointment or filling a prescription, use these steps to confirm your actual coverage:
If Aetna denies a claim or prior authorization for depression treatment, you have a clearly defined appeals path under Maine and federal law:
For ERISA self-funded plan denials, contact the DOL Employee Benefits Security Administration (EBSA) at 1-866-444-3272.
Klarity Health connects patients across Maine with licensed psychiatric providers who specialize in depression treatment, including medication management and therapy coordination. With 2,000+ licensed providers in our network, Klarity offers same-week telehealth appointments for depression evaluation and treatment.
Klarity’s providers are equipped to manage first-line antidepressants (SSRIs, SNRIs, bupropion) and can coordinate referrals for more complex cases requiring Spravato or intensive-level care. Our team can also help you navigate Aetna’s prior authorization process for medications that require PA.
Check if your Aetna plan may cover depression treatment through Klarity Health: Learn more about online depression treatment →
Aetna typically covers telehealth therapy for depression in Maine at parity with in-person care. Maine law requires insurers to cover telehealth services for mental health conditions at parity. Verify your specific plan’s telehealth benefits by calling 1-800-872-3862.
Aetna may cover Spravato for treatment-resistant depression or MDD with acute suicidal ideation, subject to prior authorization through CVS/Caremark and enrollment in the Spravato REMS program. At least two prior antidepressant trial failures are typically required. Spravato is a Schedule III substance. Prescribers in Maine must issue the prescription electronically (EPCS REQUIRED).
Many Aetna plans in Maine do not require a referral for outpatient mental health visits, but some HMO plans may. Check your specific plan documents or call member services at 1-800-872-3862 to confirm whether a referral is needed.
Generic SSRIs (sertraline, escitalopram, fluoxetine), SNRIs (venlafaxine ER, duloxetine), bupropion XL, and mirtazapine are typically covered at Tier 1. 2 with no prior authorization under CVS/Caremark. Branded agents such as Trintellix, Auvelity, and Spravato require step therapy or prior authorization. Call CVS/Caremark at 1-800-552-8159 to verify your specific plan.
Me. Rev. Stat. Ann. tit. 24-A, § 2749-A requires fully-insured Maine health plans to cover mental health conditions, including depression, at parity with medical and surgical benefits. Aetna may not impose more restrictive prior authorization, step therapy, or cost-sharing requirements for depression care than for comparable physical health services.
If CVS/Caremark or Aetna denies your antidepressant prescription, you can request a peer-to-peer review (your provider calls Aetna’s medical director), file an internal appeal (Aetna must respond within 30 days standard / 72 hours urgent), and if still denied, request an external independent medical review through the Maine Bureau of Insurance at 1-800-300-5000.
Coverage disclaimer: Insurance coverage for depression treatment varies by plan, employer group, benefit year, and individual circumstances. The information on this page reflects typical Aetna and CVS/Caremark practices as of 2026 and is intended for general informational purposes only. It does not constitute a guarantee of coverage. Always verify your specific benefits with Aetna at 1-800-872-3862 and CVS/Caremark at 1-800-552-8159 before scheduling appointments or filling prescriptions. Klarity Health is an independent telehealth provider and is not affiliated with Aetna or CVS/Caremark.
Find the right provider for your needs — select your state to find expert care near you.